Cancer

Learn how scientists have used Mabtech solutions in their cancer research. From evaluating novel cancer vaccines to screening tumor-infiltrating lymphocytes or CAR T cells, see how Mabtech ELISpot, FluoroSpot, and ELISA can answer your research questions and help bring your immunotherapy to market.

Highlighted research, Published October 13, 2023

ELISpot in cancer research

ELISpot and FluoroSpot assays are used to study rare cells in cancer research. Our white paper "ELISpot in cancer research" provides an overview of their application in various cancer studies.

Highlighted research, Published September 20, 2018

ELISpot instrumental in finding breast cancer-reactive T cell clones

The authors sequenced breast cancer lesion for somatic mutations, and subsequently screened TILs for reactivity to identify neoantigens using Mabtech IFN-γ ELISpot.

Highlighted research, Published January 22, 2024

Using ELISpot to evaluate personalized RNA neoantigen vaccines in pancreatic cancer

Explore how Mabtech’s ELISpot Pro: Human IFN-γ, kits contributed to cutting-edge cancer vaccine research, as demonstrated in a recent study on personalized RNA neoantigen vaccines in pancreatic cancer.

Highlighted research, Published January 22, 2024

Using ELISpot to evaluate personalized RNA neoantigen vaccines in pancreatic cancer

Highlighted research, Published December 10, 2018

2018 Nobel laureate used Mabtech ELISpot

Nobel laureate Professor James P. Allison has been using Mabtech ELISpot: human IFN-γ throughout his research career.